BioPhausia submits application for registration of RescueFlow

BioPhausia submits application for registration of RescueFlow® An application for registration of RescueFlow® - BioPhausia's product for treatment of casualties with extensive haemorrage in connection with injuries - has been submitted to the Swedish Medical Products Agency. A mutual approval procedure is employed, under which Swedish approval and the Swedish file are used when applying for approval in other EU countries. Uppsala, January 13, 1998 Please contact the Vice-president, Richard Hainsworth, for further information. Tel. +46-18-34 99 00 Based on its contact network and know-how, primarily in connective- tissue biology, BioPhausia is developing products for licensing to well-established pharmaceutical companies with strong marketing organizations. The project portfolio includes RescueFlow®, a resuscitation solution (registration phase), Krillase® for the debridement of chronic wounds (clinical phase III), and preclinical projects in the tumor and trauma treatment areas.